New study highlights the importance and potential promise of targeting structures other than cartilage pathology for the treatment of osteoarthritis BOSTON UNIVERSITY SCHOOL OF MEDICINE (Boston)– Bisphosphonates (a class of drugs that prevent the loss of bone density and used to treat osteoporosis and similar diseases) appear to be safe and beneficial for osteoarthritis patients....
Tag: <span>bisphosphonates</span>
Post
Bone disease medications may reverse hearing loss
by Ryan Jaslow, Harvard Medical School Preliminary findings from Harvard Medical School researchers at Massachusetts Eye and Ear may pave the way for trials to test bone density medications for hearing loss. Hearing loss caused by damaged nerves, whether from sound exposure or aging, is irreversible. There are currently no medications approved by the Food...
Post
USC research shows remedy for painful jaw disease
A new treatment method could help cancer patients and others by eliminating an agonizing side effect called osteonecrosis of the jaw UNIVERSITY OF SOUTHERN CALIFORNIA USC researchers and collaborators report a breakthrough to prevent damage to the jaw, a side effect suffered by some people undergoing treatment for cancer or osteoporosis. The newly published research is an important step toward...
Post
Specific long-term therapy may not prevent fractures in older women
Osteoporosis is a disease that causes thinning of the bones, loss of bone density, and increasingly fragile bones. This puts people at higher risk for bone fractures. Risk for the disease increases as we age. In fact, 50% of women over the age of 50 will experience a bone facture due to osteoporosis. By 2020,...